Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.31B P/E - EPS this Y 47.50% Ern Qtrly Grth -
Income -226.54M Forward P/E -12.87 EPS next Y 45.20% 50D Avg Chg -9.00%
Sales 331.41M PEG -0.16 EPS past 5Y - 200D Avg Chg -27.00%
Dividend N/A Price/Book N/A EPS next 5Y 44.80% 52W High Chg -55.00%
Recommedations 2.00 Quick Ratio 2.97 Shares Outstanding 206.15M 52W Low Chg 3.00%
Insider Own 1.22% ROA -11.57% Shares Float 190.88M Beta 1.93
Inst Own 88.08% ROE - Shares Shorted/Prior 32.25M/29.10M Price 6.95
Gross Margin 34.63% Profit Margin -68.36% Avg. Volume 2,556,691 Target Price 13.82
Oper. Margin -40.41% Earnings Date May 6 Volume 5,164,701 Change -0.29%
About BioCryst Pharmaceuticals, Inc.

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX10013, an oral factor D inhibitor for complement-mediated diseases. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Ltd.; Seqirus UK Limited; Shionogi & Co., Ltd.; Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.

BioCryst Pharmaceuticals, Inc. News
04/22/24 With 80% ownership, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) boasts of strong institutional backing
04/22/24 BioCryst to Report First Quarter 2024 Financial Results on May 6
04/17/24 BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
04/10/24 12 Best Depressed Stocks To Buy in 2024
04/03/24 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03:01 PM BioCryst to Present at Upcoming Investor Conferences
03/13/24 13 Best Biotech Stocks To Buy Under $20
03/01/24 Hidden Penny Gems: 7 Stocks With Triple-Digit Growth Prospects
02/28/24 BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q4 2023 Earnings Call Transcript
02/27/24 BioCryst Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
02/27/24 Q4 2023 BioCryst Pharmaceuticals Inc Earnings Call
02/26/24 BioCryst Pharmaceuticals (BCRX) Q4 2023 Earnings Call Transcript
02/26/24 BioCryst Pharmaceuticals (BCRX) Reports Q4 Loss, Tops Revenue Estimates
02/26/24 BioCryst Pharmaceuticals Inc (BCRX) Reports Growth in ORLADEYO Revenue and Projects ...
02/26/24 BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
02/23/24 BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reductions After Beginning ORLADEYO® (berotralstat) Treatment
02/19/24 BioCryst Launches ORLADEYO® (berotralstat) in Italy
02/12/24 BioCryst to Report Fourth Quarter 2023 Financial Results on February 26
02/05/24 BioCryst to Present New ORLADEYO® (berotralstat) Real-world Data at 2024 American Academy of Allergy, Asthma & Immunology Annual Meeting
01/09/24 BioCryst (BCRX) Moves 25.6% Higher: Will This Strength Last?
BCRX Chatroom

User Image an_Dro Posted - 4 hours ago

$BCRX Jon...listen to me...its time...let it go... take the offer its best for everyone... move on man

User Image JHSSSS Posted - 4 hours ago

$BCRX What’s with the guy with fetal alcohol syndrome on the career page?

User Image Nibbler Posted - 5 hours ago

$BCRX Any Bama football games coming up? Just thinking maybe team morale? It's pricey but worth it if we can keep the exec team feeling good and focused on building shareholder value.

User Image fergus0123 Posted - 5 hours ago

$BCRX in all seriousness. How many shares do all of you actually own?

User Image Lastcall Posted - 5 hours ago

$BCRX Let's see the grant post again. SMH, we haven't seen one in a long time at least 3 weeks 😂

User Image Lastcall Posted - 6 hours ago

$BCRX Someone getting us back for Biowars 😂 Probably..I don't like losing money but damn that was fun ..Not anymore

User Image Noto_SoFi_Goat Posted - 6 hours ago

$BCRX Let that sink in. BCRX has an FDA approved drug and you can buy a share of this company for less than arguably the most famous burger in American history. A "burger" that is no longer even close 100% beef. Good God Jon, you are a miserable failure. But hey, you're a millionaire. God Bless America!

User Image Noto_SoFi_Goat Posted - 6 hours ago

$BCRX A Big Mac costs more than 1 share of BCRX!

User Image Sedocan Posted - 6 hours ago

$BCRX wouldn't be surprised if Rapivab stockpile increase at some point. Seeing this more often in the news... "USDA has identified spread between cows within the same herd, spread from cows to poultry, spread between dairies associated with cattle movements, and cows without clinical signs that have tested positive." In 1 case, H5N1 was found in a lung tissue sample.

User Image buy_undervalued_stocks Posted - 6 hours ago

$BCRX

User Image Lastcall Posted - 6 hours ago

$BCRX Remember when Stonehouse posted he was doing an offering and then pulled it back ..What a Fking Idiot

User Image Lastcall Posted - 7 hours ago

$BCRX I said to myself don't buy anything this week nothing just hold what I have. Why didn't I listen to myself WHYYY

User Image fergus0123 Posted - 7 hours ago

$BCRX each and every one of you can spend an eternity in damnation for all I care. None of you are really owns shares.

User Image fergus0123 Posted - 7 hours ago

$BCRX I hope Stoney d👁️s

User Image celebratelife Posted - 7 hours ago

$BCRX I warned Jon Stonehouse a long time ago. I hate telling ineffective, self-serving CEO's I Told You So. But they don't give a damn about shareholders when they keep racking up huge salaries and bonuses and the Board and Management apparently scratch each others' backs. Main problem with Biocryst is management, and in particular Jon Stonehouse. I said this a long time ago, I say it again. Wall Street is unforgiving when it comes to lousy management. They have some good people but the problem is at the very top, and a bloated ship in terms of expenses, and a CEO who is clueless about what constitutes shareholder value and how to build company value (which accountants measure in dollars and nothing else).

User Image St0ckt0k101 Posted - 8 hours ago

$BCRX market 🧢 approaching 900M is crazy!! Might have to buy more under $4! I thought 1.2B was cheap market 🙄💀📉

User Image buy_undervalued_stocks Posted - 8 hours ago

$BCRX LOL, this stock price action couldn't happen to a more deserving Fucktard CEO!!!

User Image Heb1972 Posted - 8 hours ago

$BCRX institutional self induced squeeze , wait for it🤙💡💰

User Image Lastcall Posted - 9 hours ago

$BCRX Bought more at 4.20 but have a feeling the market is going to take a giant shit tomorrow. META fuck you

User Image Heb1972 Posted - 9 hours ago

$BCRX probably close to 40,000,000 shares short and only 12,000,000 currently not owned by institutional investors 🧐 let’s see how this turns out😂 the rest of retail will get pushed on the way up and then price continues upward as shorts “ institutional investors” cover increasing price to where the buyout price has been negotiated 🤷‍♂️ sit tight🤙⏰🌴

User Image SNOB_ORDER Posted - 9 hours ago

$BCRX

User Image JHSSSS Posted - 10 hours ago

$BCRX Are the inducement grants useless to the employees at this point??

User Image DinoMcnuggets Posted - 10 hours ago

$BCRX Another look at the life time chart here. Look how silly this chart is. Put your life savings in at 2$ and retire at 10-15$. Algorithms are a very powerful thing. Not sure if it's going below 4$, but this is just amazing. 8 pump and dumps in the last 35 years.

User Image justfkntrade Posted - 10 hours ago

$BCRX another dogshit day, any lower and I have to add, I’ve already lost life changing money riding it from $20 down, might as well risk some more and try to ride it back up again.

User Image DinoMcnuggets Posted - 10 hours ago

$BCRX This is the long term RSI (20+ Years) Risk to reward looks good in this area. It can go lower, but I would say 3.5 would be the potential bottom here, whether it gets that low or not is pretty hard to tell.

User Image Mercator_Constantine Posted - 10 hours ago

$BCRX are you all prepared for 10013 to fail and Nuke this puppy to 1x revenues?

User Image Stash_Cash Posted - 10 hours ago

$BCRX oh my.

User Image rconnersom685 Posted - 11 hours ago

$BCRX Jon you could be the hero tomorrow and end this fraudulent market action by scrapping the pipe and selling the company with Orladeyo for 2-3B. Your employees would do well and so would you. What are you waiting for? You are letting them drive this down to nothing with still such a strong hand. Why?

User Image Chillykid Posted - 11 hours ago

$BCRX WTF???

User Image Sedocan Posted - 11 hours ago

$BCRX I will miss this dip

Analyst Ratings
Needham Buy Apr 10, 24
Needham Buy Jan 8, 24
Needham Buy Nov 6, 23
RBC Capital Outperform Sep 25, 23
RBC Capital Outperform Sep 18, 23
RBC Capital Sector Perform Aug 4, 23
Jefferies Buy Aug 4, 23
HC Wainwright & Co. Buy Aug 4, 23
Needham Buy Aug 3, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Stonehouse Jon P President & CEO President & CEO Feb 01 Sell 10.38 100,000 1,038,000 1,008,739 02/02/23
Stonehouse Jon P President & CEO President & CEO Feb 01 Option 5.45 100,000 545,000 1,108,739 02/02/23
LEE KENNETH B JR Director Director Jan 31 Option 1.71 15,000 25,650 52,118 02/02/23
Sheridan William P Chief Medical Office.. Chief Medical Officer Mar 10 Option 3.22 148,302 477,532 199,093 03/14/22
Sheridan William P Chief Medical Office.. Chief Medical Officer Mar 10 Sell 17.26 161,139 2,781,259 37,954 03/14/22
Jones Michael L Exec. Director, Fina.. Exec. Director, Finance - PAO Mar 01 Option 4.73 2,300 10,879 13,498 03/03/22
Jones Michael L Exec. Director, Fina.. Exec. Director, Finance - PAO Mar 01 Sell 17.2 2,300 39,560 11,198 03/03/22
Stonehouse Jon P President & CEO President & CEO Jan 11 Option 4.73 184,000 870,320 1,085,602 01/13/22
Stonehouse Jon P President & CEO President & CEO Jan 11 Sell 15.04 184,000 2,767,360 901,602 01/13/22
Sheridan William P Chief Medical Office.. Chief Medical Officer Jun 01 Option 5.26 163,573 860,394 106,289 06/01/21
Sheridan William P Chief Medical Office.. Chief Medical Officer Jun 01 Sell 15.01 163,573 2,455,231 14,475 06/01/21
Barnes Alane P Senior VP, Chief Leg.. Senior VP, Chief Legal Officer Dec 15 Option 4.15 13,741 57,025 121,802 12/15/20